Search Results - "Hart, Bryan E."
-
1
Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy
Published in PLoS neglected tropical diseases (12-12-2016)“…Buruli ulcer (BU) vaccine design faces similar challenges to those observed during development of prophylactic tuberculosis treatments. Multiple BU vaccine…”
Get full text
Journal Article -
2
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer
Published in PLoS neglected tropical diseases (01-09-2015)“…Buruli ulcer, an emerging tropical disease caused by Mycobacterium ulcerans (MU), is characterized by disfiguring skin necrosis and high morbidity. Relatively…”
Get full text
Journal Article -
3
Cell Surface Trafficking of TLR1 Is Differentially Regulated by the Chaperones PRAT4A and PRAT4B
Published in The Journal of biological chemistry (11-05-2012)“…The subcellular localization of Toll-like receptors (TLRs) is critical to their ability to function as innate immune sensors of microbial infection. We…”
Get full text
Journal Article -
4
Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria
Published in The Journal of immunology (1950) (01-12-2012)“…We recently identified I602S as a frequent single-nucleotide polymorphism of human TLR1 that greatly inhibits cell surface trafficking, confers…”
Get full text
Journal Article -
5
Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection
Published in Journal of Tropical Medicine (01-01-2012)“…Genetic association studies of leprosy cohorts across the world have identified numerous polymorphisms which alter susceptibility and outcome to infection with…”
Get full text
Journal Article -
6
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors
Published in Clinical and vaccine immunology (01-07-2015)“…The well-established safety profile of the tuberculosis vaccine strain, Mycobacterium bovis bacille Calmette-Guérin (BCG), makes it an attractive vehicle for…”
Get full text
Journal Article -
7
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer: e0004046
Published in PLoS neglected tropical diseases (01-09-2015)“…Buruli ulcer, an emerging tropical disease caused by Mycobacterium ulcerans (MU), is characterized by disfiguring skin necrosis and high morbidity. Relatively…”
Get full text
Journal Article -
8
TLR1 I602s: Trafficking dynamics and roles in resistance to mycobacterial infection
Published 01-01-2012“…Innate immunity provides defense mechanisms required for protection against constant exposure to potentially pathogenic microorganisms. Essential to this role…”
Get full text
Dissertation -
9
Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer
Published in Trials in vaccinology (2016)“…Mycobacterium ulcerans (MU) infection causes the disfiguring necrotic skin disease, Buruli ulcer (BU). While vaccination with Mycobacterium bovis BCG provides…”
Get full text
Journal Article